Boston Harbor Angels
Brendan McKernan was a co-founder of Agencourt Bioscience Corporation and Agencourt Personal Genomics. Until both firms were acquired, he was Vice President of Operations. In this capacity, he oversaw the implementation and execution of the company's operational strategy.
Massachusetts-based Agencourt Biosciences Corporation was a leading provider of nucleic acid purification products and genomic services for life science research. Agencourt employed 140 people and delivered 30% EBITDA margins and a 13X ROI to its shareholders. Agencourt Bioscience was acquired by Beckman Coulter in 2005. Agencourt Personal Genomics developed the SOLiD sequencing platform that was acquired by Life Technology in 2006.
McKernan holds a BS in Management Science from Muhlenberg College in Allentown, Pa., and an MBA from Rensselaer's Lally School of Management and Technology. While at Rensselaer, McKernan received the Delmar W. Karger Award in Management for outstanding academic and leadership achievements. McKernan was named the 2006 William F. Glaser '53 Rensselaer Entrepreneur of the Year.
McKernan is currently a founding member and managing partner of Courtagen Capital Group. Courtagen is a Life Science operating group that recently acquired assets of a biomarker technology. Mckernan co -founded a new entity called Avantra Bioscience to commercialize the biomarker technology. McKernan is the Chief Operating Officer and board member of Avantra Bioscience.
Mckernan is currently a board member of the Avon Old Farms School and a
member of the advisor council for Rensselaer's Lally School of Management.
McKernan is a judge for the Lemelson Program which celebrates and supports
inventors and entrepreneurs in order to strengthen social and economic life.